Journal article

Understanding CD30 biology and therapeutic targeting: a historical perspective providing insight into future directions

CA van der Weyden, SA Pileri, AL Feldman, J Whisstock, HM Prince

Blood Cancer Journal | NATURE PUBLISHING GROUP | Published : 2017


Funding Acknowledgements

SAP is a member of the speaker bureau for Takeda Pharmaceutical Company and Seattle Genetics. HMP is an Advisory Board Member and has received research support from Takeda Pharmaceutical Company. The remaining authors declare no conflict of interest.